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LRRl control of Drosophila Bone Morphogenetic Protein (BMP) signaling is achieved
by a host of extracellular factors that modulate ligand distribution and activity. Here we describe Kekkon5
(Kek5), a transmembrane protein containing leucine-rich repeats (LRRs), as a novel regulator of BMP
signaling in Drosophila. We ﬁnd that loss or gain of kek5 disrupts crossvein development and alters the early
proﬁle of phosphorylated Mad and dSRF in presumptive crossvein cells. kek5 phenotypic effects closely
mimic those observed with Short gastrulation (Sog), but do not completely recapitulate the effects of
dominant negative BMP receptors. We further demonstrate that Kek5 is able to antagonize the BMP ligand
Glass bottom boat (Gbb) and that the Kek5 LRRs are required for BMP inhibitory activity, while the Ig domain
is dispensable in this context. Our identiﬁcation of Kek5 as a modulator of BMP signaling supports the
emerging notion that LIG proteins function as diverse regulators of cellular communication.
© 2008 Elsevier Inc. All rights reserved.IntroductionPrecise spatial and temporal control of cellular signal transduction
is an essential feature of animal development, and is often achieved by
accessory proteins that inﬂuence the activity, availability, distribution
or modiﬁcation of core signaling components. A classic example of
this is the Bone Morphogenetic Protein (BMP) signaling pathway,
which regulates the patterning and growth of tissues across animal
taxa.
In Drosophila, the major BMP-like ligand Decapentaplegic (Dpp)
plays major roles in patterning both the early embryo and the adult
appendages (Segal and Gelbart, 1985). During larval stages, BMP
signaling regulates the growth and patterning of the wing imaginal
disc; later during pupal development the BMP pathway cooperates
with the EGFR and Notch signaling pathways to control formation of
the wing veins. Dpp cooperates with the additional BMP-like ligands
Screw (Scw) and Glass bottom boat (Gbb) during embryonic and
larval/pupal stages, respectively (Arora et al., 1994; Haerry et al., 1998;
Khalsa et al., 1998). Current evidence suggests that heterodimeric
ligands represent the primary contributors to in vivo signaling
(Shimmi et al., 2005b). BMP signals in the wing are transduced by a
serine/threonine kinase receptor complex combining the common
type II receptor Punt (Put) with alternate type I receptors Thickveins
(Tkv) and Saxophone (Sax) (Brummel et al., 1994; Letsou et al., 1995;
Nellen et al., 1994; Penton et al., 1994; Ruberte et al., 1995; Xie et al.,l rights reserved.1994). Receptor activation results in phosphorylation of the cyto-
plasmic mediator Mothers against Dpp (Mad) (Sekelsky et al., 1995).
BMP ligands are subject to extracellular regulation by a number of
secreted factors: Short gastrulation (Sog) forms an inhibitory complex
with BMP ligands along with Twisted gastrulation (Tsg, in embryos)
or Tsg2 (in pupal wings), preventing short-range activation while
promoting long-range signaling by facilitating ligand diffusion (Ashe
and Levine, 1999; Mason et al., 1994; Ross et al., 2001; Shimmi et al.,
2005a). Sog is cleaved by the tissue-speciﬁc metalloproteases Tolloid
(Tld, in embryos) and Tolloid-related (Tlr, a.k.a. Tolkin, in pupal
wings), releasing active ligand dimers (Marques et al., 1997; Serpe
et al., 2005).
BMP ligands produced in the longitudinal veins diffuse into
crossvein-competent regions to initiate crossvein development during
pupal stages (Ralston and Blair, 2005), making the crossveins highly
sensitive to ﬂuctuations in BMP signaling levels. This is especially true
of the posterior crossvein (PCV), which must span a greater distance
between BMP-producing longitudinal veins than the smaller anterior
crossvein (ACV) (Ralston and Blair, 2005). Numerous recent reports
have utilized the PCV to characterize new components of BMP
signaling and to further investigate the relationships between existing
members (Conley et al., 2000; Ralston and Blair, 2005; Serpe et al.,
2005; Shimmi et al., 2005a; Vilmos et al., 2005). For example,
molecular characterization of classic crossveinless mutants has
revealed that crossveinless (cv) encodes Tsg2, which along with Sog
mediates BMP ligand diffusion from the longitudinal veins to the PCV
(Bridges, 1920; Shimmi et al., 2005a; Vilmos et al., 2005), while
crossveinless-2 (cv-2) encodes a BMP-binding protein with Sog-like
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(Conley et al., 2000). BMP signaling during vein development is
further modulated by the PS integrins, which in addition to their
canonical role in adhesion inﬂuence extracellular Sog distribution in
the pupal wing (Araujo et al., 2003). It is therefore becoming
increasingly clear that a host of diverse factors cooperate to ensure
proper spatiotemporal activation of the BMP pathway.
Here we describe a novel regulator of BMP signaling during
crossvein formation in Drosophila, Kekkon5 (Kek5). Kek5 is a
transmembrane leucine-rich repeat (LRR) and immunoglobulin-like
(Ig) domain containing (LIG) protein and one of six members of the
Kek family, a suite of related transmembrane LIG proteins in Dro-
sophila (MacLaren et al., 2004). Kek5 is expressed broadly through-
out development and like kek1 and kek2 is enriched in the
developing embryonic central nervous system (CNS) (MusacchioFig. 1. kek5 gene structure and expression pattern. (A) Structure of the kek5 gene and Kek5 pr
mutants are denoted by inverted triangles. Extent of deletions in kek5Δ1 and kek5fe148 are in
ending 58 bp downstream of exon 1. kek5fe148 is a 48 kb deletion, removing the ﬁnal exon
within the last intron of CG32533. The small predicted gene CG32827 resides within the 70 kb
instar wing discs (E, F), and pupal wings (G, I). Kek5 is broadly expressed at these developm
kek5fe148 (D, F, H). Staining remains within the CNS of kek5Δ1 animals (C) but is undetectab
antisera. Kek5 is broadly expressed in pupal wings. G and I represent different optical section
and arrow) demonstrating Kek5 expression is present in both vein and intervein regions. For
is left and anterior is up. Black boxes in (A) indicate untranslated regions; white boxes repre
rich cap; LRRs, leucine-rich repeats; Ig, immunoglobulin-like domain; Tm, transmembrane
cytoplasmic sequence motifs.and Perrimon, 1996). Loss of kek5 leads to defects in crossvein
formation due to decreased BMP signaling in presumptive crossvein
cells, as indicated by alterations in the proﬁle of phosphorylated
Mad (pMad) and dSRF in pupal wings. Similarly, increased kek5
expression disrupts BMP signaling in presumptive crossvein cells
and causes loss of crossvein in adult wings. kek5 loss and gain of
function phenotypes closely resemble those of sog yet are dissimilar
to those of BMP receptors, suggesting that Kek5 acts upstream of the
receptors to modulate pathway activity. Consistent with this idea,
Kek5 is able to suppress phenotypes caused by increased BMP ligand
activity. Finally, we demonstrate that the LRRs of Kek5 are required
for its BMP inhibitory activity, perhaps indicating that Kek5 acts
similarly to the vertebrate LRR proteins Tsukushi (Tsk) and Biglycan
(Bgn) to regulate the activity and/or extracellular distribution of BMP
ligands.otein. Positions of P (P) and piggyBac (pB) transposable elements used to create deletion
dicated below the gene. kek5Δ1 is an 840 bp deletion, beginning 426 bp upstream and
of CG32533 and ending 9 bp upstream of the start of transcription of CG12200, located
second intron of kek5. (B–J) Kek5 antiserum staining is shown in embryos (B, C, D), third
ental stages in wild type (B, E, G, I, J), while staining is undetectable in the null mutant
le in other tissues (not shown). Inset in (E) highlights membrane localization of Kek5
s and J is a magniﬁed viewwith the vein intervein boundaries indicated (see dashed line
all embryos, anterior is left and dorsal is up. For all wing discs and pupal wings, proximal
sent protein-coding sequences. N, N-terminal cysteine-rich cap; C, C-terminal cysteine-
region; and IC, intracellular region. Black boxes numbered 1–6 represent conserved
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Drosophila genetics
Flies were raised on standard medium at 27 °C unless otherwise
noted. GAL4/UAS stocks used included: P{GawB}apmd544 (ap-GAL4), P
{GawB}559.1 (ptc-GAL4), P{en2.4-GAL4}e16E (en-GAL4), P{GawB}
BxMS1096 (MS1096-GAL4), and P{GawB}CY2 (CY2-GAL4); P{UAS-sog}
and P{UAS-supersog} (Yu et al., 2000), P{UAS-tkvA} (activated Tkv), P
{UAS-saxA} (activated Sax), P{UAS-tkv1AΔGS} (dominant negative
Tkv), and P{UAS-saxΔI} (dominant negative Sax) (Haerry et al., 1998),
and P{UAS-gbb.K} (Khalsa et al., 1998).
Kek5 and Kek4 misexpression constructs: full or partial ORFs were
ampliﬁed via PCR and cloned using Gateway recombination methods
(Invitrogen) into a pUAST-GFP destination vector. Transgenic ﬂies
were produced using standard germline transformation techniques
(Spradling, 1986). Adult wings were dissected in isopropanol and
mounted in 80% Canada balsam, and 20% methyl salicylate. Images
were captured on a Zeiss Axiophot microscope.
Generation of kek5 mutants
The kek5Δ1 allele was generated via imprecise excision of the P
{GT1}kek5BG02535 P element located within the ﬁrst intron of kek5 and
conﬁrmed by PCR and sequence analysis. kek5fe148 was generated via
FLP-mediated mitotic recombination between PBac{WH}f04013 and
PBac{RB}CG32533e00904 (Parks et al., 2004). Putative deletions were
conﬁrmed by PCR analysis and antibody staining.
Immunohistochemistry
Embryos and imaginal discs were stained according to standard
protocols. Embryos were ﬁxed in PBS containing 10% paraformalde-Fig. 2. kek5 mutant wings exhibit defects in crossvein patterning and epithelial adhesion.
posterior crossvein (PCV) are indicated in panel A. kek5mutant wing defects include truncate
PCV (arrow in panel D), ectopic crossveins around the ACV (arrow in panel E), and wing blis
adult ﬂies with defects in one or bothwings. Percent crossvein defect includes all phenotypes
listed.hyde and 50 mM EGTA; subsequent steps were carried out in PBS plus
0.5% NP-40 and 0.1% BSA. Imaginal discs were ﬁxed in 1% formalde-
hyde, 100 mM PIPES, 2 mM MgSO4, 1 mM EDTA, and 0.5% NP-40;
subsequent steps were carried out in PBS plus 0.5% NP-40 and 0.1%
BSA.
White prepupae were collected, aged, dissected in Drosophila
Ringer's, and ﬁxed 4–5 h in Brower ﬁx (2% formaldehyde, 100 mM
PIPES, 2 mM MgSO4, 1 mM EGTA, and 1% NP-40). Pupal wings were
dissected away, blocked with 0.5% BSA for 1–3 h, incubated with
primary antibody overnight, washed and incubated with secondary
antibody for 1. 5 h, thenwashed andmounted in 70% glycerol/PBS plus
Slowfade (Molecular Probes). All incubation and wash steps were
carried out in PBS plus 0.3% Triton X-100 at 4 °C.
To generate Kek5 antisera, a unique C-terminal Kek5 peptide
(CGSTSQLFDDEGEDGTEV) was conjugated to keyhole limpet hemo-
cyanin and used to immunize rabbits (Cocalico). Polyclonal antisera
were pre-adsorbed twice at 1:10 dilution against kek5fe148 null
embryos and used at a ﬁnal dilution of 1:100. Anti-pMad antibody
(Persson et al., 1998) and dSRF were used at 1:5000 and 1:1000 (Santa
Cruz Biotechnology), respectively. Secondary antibodies used were:
goat anti-rabbit Alexa488 and goat anti-rabbit Alexa568 (both 1:400;
Molecular Probes). Fluorescence images were captured using a Leica
TCS SP confocal microscope or Zeiss Axio Imager equipped with an
ApoTome.
Results
Kek5 is a LIG family member expressed broadly in development
The Drosophila proteome includes nine proteins that combine LRRs
with Ig domains, termed LIGs (MacLaren et al., 2004). Six of these
proteins exhibit signiﬁcant sequence and structural similarity and
represent the Kekkon (Kek) family. Within the Kek family, only Kek1'sComparison of wild type (A) with kek5fe148 (B–F) wings. Anterior crossvein (ACV) and
d ormissing PCV (arrow in panel B), ectopic PCVmaterial (arrow in panel C), meandering
ters (F). (G) Frequency of wing defects in kek5 mutants. Numbers indicate percentage of
shown in panels B–E. Phenotypes shown for kek5fe148 are representative of all genotypes
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unique among family members. In order to determine whether other
Kek proteins might regulate distinct signaling pathways, we have
undertaken an assessment of the additional family members and
describe here our analysis of Kek5.
The kek5 transcription unit covers 117 kb on the X chromosome
and encodes a transmembrane molecule with an extracellular
domain combining seven LRRs ﬂanked by cysteine-rich regions
with a single C2-type Ig domain, typical of Kek family proteins (Fig.
1A, Fig. S1) (MacLaren et al., 2004; Musacchio and Perrimon, 1996).
The Kek5 cytoplasmic tail contains no apparent catalytic domain;
however, comparison of orthologs in mosquito, honeybee and ﬂour
beetle revealed short, highly conserved sequence motifs spaced
throughout this otherwise divergent region (Fig. S1) (MacLaren et al.,
2004). This includes the last three amino acids of Kek5 (TEV), which
represent a consensus binding sequence for class I PDZ domain
proteins, suggesting a role in protein localization (Fig. S1) (Nourry
et al., 2003).
To investigate the function of Kek5, we initially characterized the
Kek5 expression proﬁle. In situ analysis of kek5 mRNA (not shown) is
consistent with the protein expression patterns. Although they share a
related structure, the overall expression pattern of Kek5 is distinct
from that of Kek1 (Fig.1) (Musacchio and Perrimon,1996). Throughout
embryonic and larval stages, Kek5 expression appears to be ubiquitous
in most tissues, and antiserum staining is membrane-localized (Figs.
1B, E, G). Kek5 appears uniformly expressed in imaginal discs (wing,
haltere, eye/antenna, and leg), and is widely expressed in both
germline and somatic cells of the adult ovary (Fig. 1E and data not
shown). This is in marked contrast to kek1, which is expressed in a
restricted pattern indicative of EGFR activation within the follicular
epithelium and imaginal discs (Musacchio and Perrimon, 1996). In
addition, Kek1, Kek2, and Kek5 all exhibit high level expression in the
embryonic central nervous system (CNS) (Fig. 1B) (Musacchio and
Perrimon, 1996). Thus, Kek5 is a broadly expressed LIG protein that,
like other Kek family members, is enriched in the developing
embryonic CNS.
Kek5 is required for proper crossvein patterning
Unlike Kek1, Kek5 does not associate with the EGFR or inﬂuence its
activity in vivo (Alvarado et al., 2004a). This, along with a more
extensive expression pattern than Kek1, suggests a distinct function
for Kek5. We therefore set out to determine the role of kek5 in vivo
using both loss of function and gain of function approaches. To disrupt
the function of kek5, we generated a series of small deletions by
excising a transposable element (kek5BG02535) located 59 bp down-
stream of kek5 exon 1 (Fig. 1A), and a larger deletion through FLP-
mediated mitotic recombination between two FRT-containing piggy-
Bac elements ﬂanking the kek5 coding region (Parks et al., 2004). One
of the small deletions, kek5Δ1, removes the entire ﬁrst exon of kek5
and 427 bp of upstream sequence and abolishes kek5 expression in
most tissues. However, mRNA and protein expression is still
detectable within the embryonic and larval CNS of kek5Δ1 animals at
comparable levels towild type (Fig.1C). In contrast, the larger deletion
kek5fe148 lacks all kek5 coding sequence and expression is undetectable
via antibody staining (Figs. 1D, F, H) or in situ hybridization (not
shown) in kek5fe148 homo- and hemizygous animals, conﬁrming its
status as a null allele. Both alleles, kek5Δ1 and kek5fe148, produce fertile
adults, similar to kek1 null mutations (Musacchio and Perrimon,
1996). In contrast to kek1, however, ﬂies mutant for kek5 display a
number of visible adult phenotypes and exhibit decreased viability.
One of the most frequent phenotypes we observed in kek5mutant
ﬂies is aberrant crossvein patterning (Fig. 2; 25–30% penetrance).
Most often full or partial truncation of the posterior crossvein (PCV)
occurs (Fig. 2B, ∼62%); less commonly the PCV appears twigged or
forked (Fig. 2C, ∼16%), or the PCV ends meander from their correctposition (Fig. 2D, ∼8%). Occasionally the PCV appears normal and
ectopic crossveins appear nearby. The anterior crossvein (ACV) is
rarely deleted or truncated in kek5mutants; more often partial or full-
length ectopic crossveins appear adjacent to the ACV (Fig. 2E, ∼14%).
The severity and penetrance of these crossvein phenotypes are
indistinguishable between kek5Δ1 and kek5fe148, consistent with the
fact that both alleles abolish kek5 expression in the developing wing
(Fig. 2G). Notably, we were unable to detect any longitudinal vein
defects in kek5mutant wings, indicating that the function of kek5may
be restricted to crossvein development. In both cases, the frequency of
defects is enhanced by hemizygosity of our alleles with large
deletions, which may simply reﬂect the notion that large deletions
can often exacerbate sensitized phenotypes.
We also note a second, apparently distinct, phenotype in kek5
mutants: wing blisters appear at low frequency (less than 5%; Fig. 2F).
Although it occurs at low penetrance, this phenotype is speciﬁc to loss
of kek5 as it does not appear in any of the progenitor strains used to
generate kek5 mutants, and appears in both kek5Δ1 and kek5fe148al-
leles when homo- or hemizygous, or when either is placed over
deﬁciencies for the region (Df(1)JA27 or Df(1)Exel7468). These wing
blisters are not simply due to the presence of ectopic vein material, as
we observed no correlation between the appearance of blisters and
the presence of ectopic crossvein. This phenotype will not be
described further here; but consistent with both phenotypes, Kek5
is expressed broadly in the pupal wing in developing vein and
intervein regions (Figs. 1G, I, J). Below we focus on the role of kek5 in
crossvein patterning.
Inhibition of BMP signaling by Kek5
Speciﬁcation of Drosophila crossveins is controlled by BMP
signaling during pupal development. BMP ligands produced in the
longitudinal veins diffuse into crossvein-competent regions to initiate
crossvein development (Ralston and Blair, 2005), making the cross-
veins highly sensitive to ﬂuctuations in BMP signaling levels. Loss of
crossvein is characteristic of alterations in BMP signaling; in particular,
mutations that interfere with BMP ligand distribution (e.g. sog, cv, tlr)
produce crossvein-speciﬁc phenotypes similar to thosewe observe for
kek5. The PCV is especially sensitive to these alterations (Conley et al.,
2000; Ralston and Blair, 2005; Serpe et al., 2005; Shimmi et al., 2005a;
Vilmos et al., 2005), raising the possibility that Kek5may participate in
BMP signaling during crossvein development.
If this is the case, increased kek5 expression should alter BMP
pathway activity and the appearance of vein. If Kek5 acts similarly to
Sog, Tsg, and CV-2 to regulate BMP ligand activity or distribution,
increased kek5 expression might promote or inhibit BMP signaling.
Consistent with the latter possibility, misexpression of kek5 through-
out the wing with a variety of GAL4 wing drivers (MS1096-GAL4, en-
GAL4, and ptc-GAL4) produced phenotypes indicative of decreased
BMP signaling, i.e. missing crossveins and decreased wing size (Fig. 3).
All misexpression phenotypes were highly penetrant and observed
with multiple independent responder lines. In addition, we observed
additional phenotypes associated with reductions in BMP signaling,
including a strong ectopic scutellar bristle phenotype (Tomoyasu et al.,
1998). These effects may also be due to downregulation of BMP
signaling by Kek5, as similar phenotypes are produced by misexpres-
sion of Sog or dominant negative Tkv with ptc-GAL4 (Figs. 3P–S).
While misexpression of Sog or Kek5 leads to local inhibition of
crossvein formation, a notable distinction between their effects is that
Sog misexpression also triggers the appearance of ectopic crossvein
material and Kek5 does not (compare Figs. 3E, G to F, H). This ectopic
vein reﬂects Sog's ability to act at a distance to potentiate BMP
signaling, and appears exclusively outside the expression domain of
the individual GAL4 drivers (ptc-GAL4 and en-GAL4; no ectopic vein
appears withMS1096-GAL4, which is expressed throughout the entire
wing blade).
Fig. 3. (A–H) Misexpression of Kek5 inhibits crossvein formation and mimics Sog. Kek5 (A) or Sog (B) misexpression throughout the entire wing with MS1096-GAL4 prevents
formation of the ACV, a distinct phenotype from dominant negative forms of Sax (C) or Tkv (D), which induce more extensive defects in longitudinal vein formation and wing
patterning. Similar Kek5 and Sog effects are produced in combination with ptc-GAL4 or en-GAL4 (E–H). Misexpression with en-GAL4 causes loss of PCV in addition to ACV, likely
owing to higher expression levels of this driver. Notably, the ACV appears more sensitive than the PCV to increases in kek5 or sog expression, in contrast to loss of function conditions.
(I–L) Kek5 promotes short-range inhibition and restricts long-range activation of BMP signaling by Sog. Removing kek5 from ptcN sog ﬂies causes an increase in ectopic vein outside of
the ptc-GAL4 expression domain, reﬂecting increased long-range BMP activation by Sog (I). In these ﬂies, a full-length ectopic crossvein appears between L4 and L5 in 33% of wings
(asterisk in panel I), but was never observed in ptcNsog ﬂies. In contrast, adding UAS-kek5 to this background decreases the amount of ectopic vein (J). Misexpression of a high-
potency form of Sog (Supersog) with ptc-GAL4 causes loss of intervein between L4 and L5 (arrow in panel K); this phenotype is suppressed by removal of kek5 (L). Asterisks (⁎ in F, H, I)
indicate ectopic vein induced by Sog misexpression, which in all cases occurs outside of the GAL4 expression domain. (M–O) Inhibition of BMP signaling, tkvDN (M) is suppressed by
removal of kek5 (N). Misexpression of tkvDN produces large gaps in L4 (class II-moderate defects) in 91% of the wings, which is suppressed ∼4.8 fold by removal of kek5 (O). (P–S)
Kek5 can modulate BMP signaling during bristle formation. Wild type ﬂies exhibit four prominent scutellar bristles (P, arrows). Ectopic scutellar bristles are induced in response to
misexpression of kek5 (Q), sog (R), or dominant negative tkv (S).
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Fig. 4. BMP pathway activation is altered by changes in Kek5 activity. Pupal wings at 24
and 30 h APF are shown. (A, B) Accumulation of pMad in wild type pupal wings
delineates the presumptive longitudinal and cross veins. (C, D) When kek5 is
misexpressed in a region overlapping the ACV, BMP signaling is abolished and the
ACV fails to form (arrowhead). (E) In kek5 mutant wings, BMP signaling is often
decreased in the presumptive PCV, leading to a truncation of this vein (arrowhead).
Arrows indicate location of presumptive ACV.
41T.A. Evans et al. / Developmental Biology 326 (2009) 36–46Can Kek5 inﬂuence Sog's ability to induce ectopic vein at a
distance? If Kek5 acts to restrict BMP ligand diffusion, then reducing
its activity should enhance the appearance of ectopic vein associated
with Sog misexpression. Consistent with this, loss of kek5 results in an
increase in ectopic crossvein material in ptcNsog ﬂies (Fig. 3I). MostFig. 5. dSRF expression is altered by changes in Kek5 activity. Pupal wings at 24 and 30 h
APF are shown. (A, B) Loss of dSRF in wild type pupal wings delineates the presumptive
longitudinal and cross veins. (C, D) When kek5 is misexpressed in a region overlapping
the ACV, dSRF expression is not downregulated and the ACV fails to form (arrow).
(E) dSRF expression in kek5 mutant wings, indicating the presence of an ectopic ACV.
Arrows indicate location of presumptive ACV.strikingly, a full-length ectopic crossvein appears between L4 and L5
in 33% of kek5fe148; ptcNsog wings (asterisk in Fig. 3I); we never
observed a full-length ectopic crossvein in this position in ptcNsog
wings, although partial crossveins frequently appear there (Fig. 3F).
We also observe a corresponding decrease in Sog-induced ectopic vein
when Kek5 levels are increased in this background (Fig. 3J), consistent
with Kek5 limiting Sog-dependent diffusion of BMP ligands. Providing
further evidence for an inhibitory component to Kek5 activity in BMP
signaling, loss of kek5 also was able to suppress BMP vein phenotypes
induced via misexpression of a dominant negative version of Tkv in
the wing (Fig. 3M–O) or a high-potency form of Sog (Figs. 3K, L).
To more directly assay the effects of Kek5 on vein patterning and
BMP signaling, we examined the proﬁle of pMad and dSRF in pupal
wings with altered Kek5 activity. Anti-pMad staining represents a
readout of BMP pathway activity and delineates the presumptive
longitudinal veins and crossveins of wild type pupal wings at 24 and
30 h APF (Figs. 4A, B). Conversely, dSRF expression delineates
intervein, becoming reduced in presumptive vein, while remaining
high in intervein regions. Consistent with kek5fe148 adult phenotypes,
loss of PCV and ectopic ACV, we detected truncated anti-pMad
staining within the presumptive PCV (Fig. 4E), and duplicated loss of
dSRF in the ACV region in kek5 mutants (Fig. 5E). To determine if thisFig. 6. Kek5 suppresses ligand-dependent increases in BMP signaling. Misexpression of
Gbb with ptc-GAL4 induces a large patch of ectopic veinwhere the ACV would normally
form (A). This phenotype is suppressed by addition of Kek5 (B), but not by addition of
the related protein Kek4 (D), which has no effect on ACV formation on its own (C).
Misexpression of activated forms of the BMP receptors Tkv (E) and Sax (G) induce more
severe phenotypes including extensive ectopic vein, fusion of longitudinal veins, and
loss of intervein regions. Kek5 is unable to suppress these phenotypes (F, H); instead we
observe what appears to be an additive effect where these wings now exhibit an
additional decrease inwing size characteristic of Kek5misexpression (see Figs. 3A, E, G).
Flies carrying tkvAwere raised at 17 °C to avoid early lethality; all others were raised at
25 °C.
42 T.A. Evans et al. / Developmental Biology 326 (2009) 36–46represented effects of Kek5 on BMP and not EGFR signaling, which
also affects crossvein patterning at 30 h APF, we took advantage of the
higher penetrance of the Kek5 misexpression phenotype and assayed
the expression of pMAD and dSRF at 24 h APF, a timepoint at which
pMAD and dSRF are under the sole control of BMP activity (Ralston
and Blair, 2005). In ptcNkek5 wings at 24 and 30 h APF, anti-pMad
staining was reduced or absent within the presumptive ACV, but
remained high in the longitudinal veins and PCV (Figs. 4C, D).
Similarly, dSRF was also affected — failing to be downregulated in the
ACV in ptcNkek5 wings at 24 and 30 h APF (Figs. 5C, D). Thus changes
in Kek5 activity alters BMP signaling in presumptive crossvein cells
upstream of pMAD and dSRF expression. Notably, the effects of altered
Kek5 activity on crossvein formation are similar to those observed for
the BMP antagonist sog (Figs. 3B, F, H), but distinct from the effects of
misexpressing dominant negative type I BMP receptors Thickveins
(Tkv) or Saxophone (Sax), which additionally induce strong defects in
longitudinal vein speciﬁcation and wing patterning (Figs. 3C, D).
Sog modulates BMP signaling by regulating the extracellular
distribution and availability of BMP ligands. Accordingly, Sog
misexpression is able to counteract ligand-dependent increases in
BMP signaling, but has no effect on phenotypes caused by
constitutively active (ligand-independent) forms of BMP receptorsFig. 7. Structure-function analysis of Kek5. (A) Schematic of Kek5 deletion variants as desc
bristles is indicated for each variant. Constructs lacking the LRRs (Kek5ΔL), transmembrane a
induce ectopic vein. Adding back the last six residues of the cytoplasmic tail (Kek5ΔIC + P) resto
cytoplasmic domain contributes to protein localization and stability. GFP ﬂuorescence inwing
and CY2-GAL4, respectively. Full-length Kek5 is expressed at high levels and appears tightly m
Kek5ΔIC + P, which lacks all but the ﬁnal six residues of the cytoplasmic tail (D, G, G′). In contra
decreased stability and localization appears more diffuse (C, F, F′). (E–G) Superﬁcial confocal s
lateral membranes. Anterior is left.(Yu et al., 2000). In contrast, the vertebrate BMP pseudoreceptor
BAMBI acts by inhibiting receptor complexes and is able to antagonize
both BMP ligands and constitutively active type I receptors
(Onichtchouk et al., 1999). The phenotypic similarities between kek5
and sog, versus dominant negative receptors, suggest that Kek5 may
likewise act upstream of BMP receptors. If this is indeed the case,
misexpression of Kek5 should be able to suppress increases in
pathway activity due to ectopic ligand production, but not mis-
expression of constitutively active BMP receptors. To test this, we
examined the effects of misexpressing Kek5 along with BMP pathway
components in the wing.
Individually, misexpression of the BMP ligand Gbb with ptc-GAL4
induces an expanded region of ectopic vein where the ACV would
normally form,while Kek5misexpression removes the ACV completely
(Figs. 3E, 6A).WhenGbbandKek5misexpression are combined, ectopic
vein is suppressed and the ACV is close to wild type (Fig. 6B). The
suppressive effect of Kek5 on Gbb is not simply the result of GAL4
titration, nor is it a common feature of Kek proteins, as we observe no
effect on the ptcNgbb phenotype when combined with UAS-kek4 (Figs.
6C, D). In contrast to the effectswithGbb, Kek5 is unable to suppress the
misexpression effects of constitutively active forms of Sax or Tkv (Figs.
6E–H). Instead, we observe an additive effect: ﬂies misexpressing bothribed in the text. The ability to disrupt crossvein formation or induce ectopic scutellar
nd cytodomains (sKek5), or cytodomain alone (Kek5ΔIC) fail to disrupt ACV formation or
res a lower level of activity. Deleting the Ig domain (Kek5ΔI) has no effect. (B–G) The Kek5
discs and egg chambers is shown for representative lines in combinationwith ptc-GAL4
embrane-localized (B, E, E′). Similar expression levels and localization are observed for
st, Kek5ΔIC, in which the entire cytoplasmic domain has been deleted, appears to exhibit
lice showing lateral follicle cell membranes; (E′–G′) deep slice showing apical, basal, and
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phenotypes comparable to activated receptor alone, plus a decrease in
wing size similar to misexpression of Kek5 alone (Figs. 6E–H).
Structural analysis implicates the LRRs and cytoplasmic domain in
BMP signaling
If Kek5 acts on extracellular components of BMP signaling, this
function should require elements of the Kek5 ectodomain. All Kek
proteins exhibit a characteristic modular arrangement of seven LRRs
combined with a single Ig domain in their extracellular portions.
However, elements of their cytoplasmic domains are also conserved
and can contribute to their function, as observed for the KT box of
Kek1 in EGFR signaling (Derheimer et al., 2004; Ghiglione et al., 2003).
To address the relative contributions of Kek5 sequence elements, we
assayed a series of Kek5 GFP-tagged variants for their ability to inhibit
BMP signaling (Fig. 7). These include deletion of the LRRs (Kek5ΔL) or
Ig domain (Kek5ΔI), a secreted form of Kek5 (sKek5) and complete
(Kek5ΔIC) or partial (Kek5ΔIC + P) deletions of the cytoplasmic domain.
Kek5ΔIC + P retains only the C-terminal six amino acids, including the
conserved PDZ domain-binding site.
Deleting the LRRs of Kek5 resulted in a near-complete loss of BMP
inhibitory activity. In contrast, a form of Kek5 lacking the Ig domain
was comparable to full-length Kek5 in its ability to inhibit crossvein
formation. The LRRs alone are not sufﬁcient for this activity, as a
secreted form of Kek5 comprising the entire ectodomain exhibited no
BMP inhibitory activity (Fig. 7A). Given the requirement for the LRRs,
one possibility is that Kek5 might function similarly to the vertebrate
LRR proteins Biglycan (Bgn) and Tsukushi (Tsk), which bind to the Sog
homolog Chordin andmodulate its afﬁnity for BMP ligands (Moreno et
al., 2005; Ohta et al., 2004). However, the inability of secreted Kek5 to
inhibit BMP signaling suggests that membrane localization may be an
integral requirement for Kek5 activity.
Previous functional analyses of Kek1 have shown that the
cytoplasmic tail, which includes a consensus PDZ-binding motif
similar to Kek5, is important for subcellular trafﬁcking and localization
(Alvarado et al., 2004a; Ghiglione et al., 2003). Consistent with this, a
variant Kek5 transgene lacking the entire cytoplasmic domain
(Kek5ΔIC) was unable to reproduce the crossvein inhibition or ectopic
bristle phenotypes of full-length Kek5, was not tightly localized to
membranes and had signiﬁcantly lower expression at the protein level
than wild type (Figs. 7B–G′, data not shown). Adding back the C-
terminal six amino acids (putative PDZ-binding motif — Kek5ΔIC + P),
restored membrane localization and expression levels comparable to
the full-length protein, but provided only a minimal increase in
activity (Fig. 7D). Thus, as in the case of Kek1 the intracellular PDZ-
binding site contributes to Kek5 localization and/or protein stability.
However, while the C-tail of Kek1 sufﬁces as the sole intracellular
component for inhibition of the EGFR, there appears to be additional
inputs from the cytoplasmic domain of Kek5 necessary to impart full
activity in BMP signaling, further distinguishing Kek5 function
mechanistically from Kek1.
Discussion
Regulation of extracellular ligand activity and distribution is
integral to achieving proper signaling levels in a number of conserved
signal transduction pathways. BMP ligands produced in the long-
itudinal veins diffuse into crossvein-competent regions to specify
development of the posterior crossvein (PCV) (Ralston and Blair,
2005), making this structure highly sensitive to ﬂuctuations in BMP
signaling levels. Recent studies focusing on BMP signaling during
crossvein development have revealed novel regulatory components
that provide precise control over BMP pathway activation, and have
provided insight into the mechanisms underlying pathway regulation
in a developmental context (Conley et al., 2000; Ralston and Blair,2005; Serpe et al., 2005; Shimmi et al., 2005a; Vilmos et al., 2005).
Here we have described a novel regulator of BMP signaling in Droso-
phila, Kek5, and added to the functions attributed to the LIG family, a
group of proteins that have emerged in recent years as a unique class
of signaling regulators.
How does Kek5 regulate BMP signaling?
Our observations suggest that Kek5 may act similarly to Sog to
regulate the extracellular distribution or activity of BMP ligands. Our
data indicate that Kek5 may inﬂuence the ability of Sog to promote
BMP ligand diffusion: in the absence of kek5, Sog's ability to promote
long-range BMP signaling is augmented, while increased levels of
kek5 abrogate this ability. Kek5 is able to antagonize the vein-
promoting activity of the BMP ligand Gbb, but is unable to counteract
ligand-independent increases in signaling caused by constitutively
active forms of the BMP receptors Tkv and Sax, consistent with a
model in which Kek5 alters extracellular activity of the pathway. We
further demonstrate that the LRRs of Kek5 are required for its
inﬂuence on BMP signaling, perhaps by mediating interactions
between Kek5 and extracellular components of the BMP pathway.
Precedence for such a model comes from recent work in vertebrates,
in which two members of the Small Leucine-Rich Proteoglycan family
(SLRP), Tsukushi (Tsk) and Biglycan (Bgn), were identiﬁed as novel
extracellular components of BMP signaling (Moreno et al., 2005; Ohta
et al., 2004). Both are small, secreted molecules containing 12 and 10
LRRs, respectively. In chick embryos, Tsk is thought to promote the
formation of the primitive streak and Hensen's node through
inhibition of BMP signaling. Its expression overlaps that of the BMP
antagonist Chordin (Chd, the vertebrate ortholog of Sog), and Tsk
forms a ternary complex with Chd and BMP capable of inhibiting BMP
signaling (Ohta et al., 2004). Likewise, in Xenopus, Moreno et al.
(2005) have shown that Bgn inhibits BMP signaling through the
formation of a ternary complex including both Chd and BMP-4, where
it appears to increase the afﬁnity of Chd for BMP-4. Although it has not
yet been demonstrated that the activities of these proteins are
mediated by their LRRs, one possibility is that the LRRs of Tsk, Bgn and
Kek5 act similarly to bind Chd/Sog and modulate its ligand afﬁnity or
diffusibility.
The activities of both Tsk and Sog have been placed upstream of
BMP receptors by showing that they can antagonize BMP ligands, but
not constitutively active receptors (Ohta et al., 2004; Yu et al., 2000);
in contrast, the vertebrate transmembrane BMP inhibitor BAMBI acts
directly on vertebrate BMP receptors, and is able to suppress the
phenotypes caused by constitutively active forms of these receptors
(Onichtchouk et al., 1999). With Kek5, we observe an effect more
similar to Tsk and Sog, supporting an extracellular role in BMP
inhibition. It is important to note however, that our results do not
exclude a more complex model invoking interactions with both
extracellular and membrane associated components (i.e. ligands and
receptors). Indeed, the requirement for membrane tethering of Kek5
and intracellular sequences in addition to the PDZ domain-binding
site for full activity provides important support for this interpretation.
A model for Kek5 function during PCV speciﬁcation
In wild type wings, BMP ligand dimers produced in longitudinal
vein cells diffuse into presumptive crossvein territories, where they
are released from Sog- and Tsg2-dependent inhibition by the
metalloprotease Tlr (Ralston and Blair, 2005; Serpe et al., 2005;
Shimmi et al., 2005a; Vilmos et al., 2005). Thus sog, tsg2 (cv), and tlr-1
are required for PCV speciﬁcation. Loss of kek5 results in both loss and
ectopic crossvein, while misexpression triggers loss of crossveins. One
simple interpretation is that the absence of kek5 leads to an altered
distribution of extracellular components, thereby failing to ensure
proper levels of BMP signaling in PCV cells. Perhaps Kek5 helps to
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interactions with either the receptors or ligands themselves. In the
absence of kek5, BMP ligand ﬂux may be more evenly distributed
across PCV and intervein cells, leading to decreased PCV signaling and
slightly increased intervein signaling (causing both loss of PCV and
ectopic vein as observed in kek5 mutant wings). In contrast, Kek5
misexpression may prevent ligand complexes from exiting the L4
territory where they are produced, thus acting as a potent crossvein
inhibitor.
Although we have to date been unable to detect speciﬁc
biochemical interactions between Kek5 and secreted BMP pathway
components, it is possible that Kek5 might interact only with a
multicomponent complex, perhaps involving Sog, Tsg2, ligand
heterodimers, and/or the receptors. Regardless, the phenotypic effects
ascribed here to Kek5 suggest the mechanism by which it modulates
BMP signaling will likely be distinct from that observed for Kek1's
regulation of the EGFR.
Kek5 versus Kek1: different pathways
Kek1 functions as an EGFR inhibitor in vivo by directly binding the
receptor and preventing its activation (Alvarado et al., 2004a;
Ghiglione et al., 2003; Ghiglione et al., 1999). kek1 expression is
induced by EGFR signaling, thereby allowing feedback attenuation of
signaling levels (Ghiglione et al., 1999). We have previously reported
that other Kek family members, including Kek5, do not inhibit EGFR
signaling, demonstrating that this is not a common feature of the Kek
family (Alvarado et al., 2004a). Here we show that Kek5modulates the
activity of a distinct signaling cascade, the Drosophila BMP pathway.
This role, as that of Kek1 in EGFR signaling, appears unique among Kek
family members as similar effects were not observed upon the loss or
gain of the activity of other members of the Kek family (data not
shown). Further distinguishing Kek5 from Kek1, Kek5 is broadly
expressed throughout development and does not appear to be
enriched in tissues or cells where BMP signaling is active, and thus
is unlikely to represent a negative feedback loop for BMP signaling.
The mechanisms by which Kek1 and Kek5 modulate signaling may
also be divergent. Kek1 acts at the receptor level by directly binding
and inhibiting EGFR; as such, Kek1 misexpression phenotypes mimic
those of dominant negative forms of EGFR. In contrast, Kek5 appears
unable to directly recapitulate the phenotypic effects of dominant
negative forms of the BMP receptors Tkv or Sax. Although it's possible
this reﬂects quantitative differences in direct receptor inhibition,
increased expression of Kek5 does not simply result in phenotypes
more akin to those observed with the receptor. Moreover, while Kek1
appears able to inhibit EGFR signaling in all developmental contexts,
the same does not appear to hold true for Kek5. For example, while we
observe BMP related phenotypes in the wing, we have been unable to
detect any alterations in embryonic dorsoventral patterning in kek5
mutant or misexpression embryos (not shown). Together, our results
support the idea that Kek5 and Kek1 modulate diverse signaling
pathways in mechanistically distinct manners, with Kek1 acting solely
via receptor binding and Kek5 likely acting in a more complex manner
perhaps altering the distribution of extracellular BMP activity either
directly or indirectly via regulation of receptor levels.
LIG proteins act as mediators and modulators in diverse signal
transduction pathways
Kek1 was among the ﬁrst proteins to be identiﬁed that combined
LRRs with an Ig domain (Musacchio and Perrimon, 1996), sequence
elements that commonly act as protein–protein interaction modules.
Many proteins possessing LRRs or Ig domains act as cell adhesion
molecules (CAMs), but the functional signiﬁcance of combining these
twomotifs in a single protein is unknown. Considering the abundance
of LRRs and Ig domains in metazoan proteomes, relatively fewproteins contain both (Pruess et al., 2003), and data addressing the
function of these proteins has only recently begun to emerge. One
apparent trend is that these LRR and Ig containing (LIG) proteins act as
mediators andmodulators in diverse signal transduction pathways, by
directly transducing signals as in the case of Trk receptors (Teng and
Hempstead, 2004) and NGL-1 (Lin et al., 2003), acting positively
within a signaling complex as with Lingo-1 (Mi et al., 2004), or
inhibiting the activity of receptors as do Kek1 (Alvarado et al., 2004a;
Ghiglione et al., 2003; Ghiglione et al., 1999) and LRIG-1 (Gur et al.,
2004; Laederich et al., 2004). Kek1 and LRIG-1 both act as modulators
of the EGFR/ErbB signaling pathway, in ﬂies and vertebrates
respectively. Although parallels between the activities of Kek1 and
LRIG-1 have been drawn, vertebrates lack an ortholog of Kek1 (LRIG1
is instead the vertebrate ortholog of the Drosophila protein Lambik)
and binding and regulation of receptor activity by these molecules
occurs via distinct mechanisms (Alvarado et al., 2004a; Alvarado et al.,
2004b; Ghiglione et al., 2003; Ghiglione et al., 1999; Gur et al., 2004;
Laederich et al., 2004; MacLaren et al., 2004), suggesting that
they each independently acquired the ability to modulate EGFR/ErbB
activity.
The Drosophila genome encodes nine LIG proteins; of these ﬁve
share sequence and structural similarity with Kek1 and represent the
Kekkon (Kek) family. All six Keks are type I transmembrane proteins
containing seven LRRs and one C2-type Ig domain in their extracellular
portions (Adams et al., 2000; MacLaren et al., 2004), a common
structural arrangement that differentiates them from Peroxidasin
(Pxn) (Nelson et al., 1994), the ﬂy LRIG-1 ortholog Lambik (Lbk) (Norga
et al., 2003), and the predicted protein CG16974, which represent the
three non-Kek Drosophila LIGs. The LRRs of Kek1 are necessary for its
interaction with dEGFR (Alvarado et al., 2004a,b; Ghiglione et al.,
2003), but no function has yet been ascribed to its Ig domain. We have
previously shown that Kek1, Kek2, Kek5, and Kek6 are evolutionarily
conserved in the insect lineage, and are able to associate in homo- and
heterotypic fashions (MacLaren et al., 2004). Further, the ability of
Kek1 to bind and inhibit dEGFR is uniquewithin the family, raising the
possibility that other Kek proteins may function as modulators of
distinct signaling pathways (Alvarado et al., 2004a). Supporting this
idea, we have shown that Kek5 acts in a distinct signaling pathway
from Kek1 (BMP rather than EGFR) and likely through a different
mechanism (regulation of ligand distribution/activity rather than
direct receptor inhibition). The analysis of Kek5 presented here thus
diversiﬁes the activities associated with LIG proteins rather than
supporting the notion that they function tomodulate a single pathway.
However, such diversiﬁcation does not formally exclude the possibility
of a common activity among family members, yet to be identiﬁed. As
such, it will be important to determine whether other LIG molecules,
including additional Kek proteins, act as modulators of signal
transduction in concert or independently.
Of the remaining four Keks, Kek4 and Kek6 aremost similar to Kek5
(forming a subgroup within the Kek family), and represent the most
likely candidates for similar function (MacLaren et al., 2004). However,
preliminarymisexpression andmutant analyses of Kek4 andKek6have
not produced Kek5-like effects, and kek5-kek4 or kek5-kek6 double
mutants display no dramatic enhancement of BMP-related kek5
phenotypes, arguing against redundant roles with Kek5 in the context
of crossvein speciﬁcation (T.A.E., unpublished). A number of the
conserved Kek5 cytoplasmic motifs are shared with Kek6 (MacLaren
et al., 2004), and our phylogenetic analyses further indicate that kek5
and kek6 are represented by a single gene in non-insect arthropods
(T.A.E., unpublished), supporting the possibility of a common, as yet
unidentiﬁed function between these closely related genes.
A common thread uniting LIG proteins is expression in the nervous
system. Indeed, the primary functions of a number of LIGs (e.g. Trk
receptors, NGL-1, LINGO-1) appear to be restricted to the nervous
system (Lin et al., 2003; Mi et al., 2004; Teng and Hempstead, 2004).
Kek1, Kek2, and Kek5 are all highly enriched in the Drosophila
45T.A. Evans et al. / Developmental Biology 326 (2009) 36–46embryonic CNS, and Kek1 and Kek2 have been implicated in the
processes of axon guidance and synapse formation, respectively (Guan
et al., 2005; Speicher et al.,1998). It remains to be determinedwhether
the roles of Kek1 and Kek5 in the CNS are related to or independent of
their respective activities as modulators of EGFR and BMP signaling.
One possibility is that the ancestral functions of Kek family members
are as CNS CAMs and that Kek1 and Kek5 (at least) have subsequently
acquired additional roles as signaling pathway modulators in other
tissues.
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